Novozymes is planning to build a new research centre with space for 800 employees in the Capital Region, reports Berlingske.
The global biotechnology company wants to create a global hub for biotech research and business development and has already purchased a 140,000 sqm area in Lyngby, 13 km north of Copenhagen.
Investment in the future
“This is an investment for the future, where the new innovation campus will be a cornerstone of our global research,” Per Falholt, the executive vice president for R&D at Novozymes, stated.
“Novozymes is driven by innovation and this centre will help strengthen our growth through developing ground-breaking biotechnology.”
Developing solutions to replace fossil fuels
Every year, Novozymes invests the equivalent of 14 percent of its revenue in research.
The company has developed over 100 different enzymes since it was spun off from Novo Nordisk and went public in 2000.
The company develops so-called biotechnological solutions designed to replace fossil fuels and create healthier food.
More than 20 percent of Novozymes’ 6,500 employees work in research and development.
Novozymes expects the inauguration of the new research centre to take place in 2018.